RaQualia Pharma Inc.
4579.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥14,039 | ¥12,562 | ¥8,037 | ¥8,320 |
| - Cash | ¥3,543 | ¥3,423 | ¥2,764 | ¥3,142 |
| + Debt | ¥3,049 | ¥3,197 | ¥3,344 | ¥3,522 |
| Enterprise Value | ¥13,545 | ¥12,336 | ¥8,617 | ¥8,700 |
| Revenue | ¥775 | ¥571 | ¥965 | ¥738 |
| % Growth | 35.8% | -40.9% | 30.8% | – |
| Gross Profit | ¥549 | ¥335 | ¥673 | ¥509 |
| % Margin | 70.8% | 58.8% | 69.7% | 69% |
| EBITDA | ¥1 | -¥185 | ¥162 | ¥5 |
| % Margin | 0.1% | -32.4% | 16.8% | 0.7% |
| Net Income | -¥214 | -¥350 | -¥5 | -¥155 |
| % Margin | -27.6% | -61.3% | -0.5% | -21% |
| EPS Diluted | -8.76 | -15.25 | -0.24 | -7.16 |
| % Growth | 42.6% | -6,254.2% | 96.6% | – |
| Operating Cash Flow | ¥70 | ¥57 | -¥302 | -¥48 |
| Capital Expenditures | -¥15 | -¥38 | -¥11 | ¥0 |
| Free Cash Flow | ¥55 | ¥20 | -¥313 | -¥48 |